FDA Psychopharm Advisory Chair Acknowledges No Evidence for SSRI Chemical Imbalance Claims_CMAJ

"Biological psychiatrists have looked very closely for a serotonin imbalance or dysfunction in patients with depression or obsessive compulsive disorder and, to date, it has been elusive," says Dr. Wayne Goodman, Chair of the US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee.

 

‘Debate’- Case Against Scientific Validity of Mental Screens– NAS- Sci-Tech Policy Fellows Seminar

The importance of debate  in science cannot be overstated. Without the challenge of debate, science is dominated by "authorities" who provide only the veneer of science without substance supported by evidence. Correct url for power point: https://ahrp.org/children/teenscreen/debateNAS0206.ppt